A case of biphenotypic blast crisis of unclassified myeloproliferative disorder

被引:0
|
作者
J. Kim
C. Park
E. Seo
J. Lee
S. Yoo
S. Choi
H. Chi
机构
[1] Department of Clinical Pathology,
[2] University of Ulsan College of Medicine and Asan Medical Center,undefined
[3] Seoul,undefined
[4] Korea,undefined
[5] Department of Clinical Pathology,undefined
[6] University of Ulsan College of Medicine and Asan Medical Center,undefined
[7] 388–1 poong-nap dong,undefined
[8] song-pa gu,undefined
[9] Seoul,undefined
[10] Korea 138–736,undefined
[11] Department of Hemato-Oncology,undefined
[12] University of Ulsan College of Medicine and Asan Medical Center,undefined
[13] Seoul,undefined
[14] Korea,undefined
来源
Annals of Hematology | 2002年 / 81卷
关键词
Biphenotypic Blast crisis Unclassified myeloproliferative disorder;
D O I
暂无
中图分类号
学科分类号
摘要
We report a first case of biphenotypic blast crisis of unclassified myeloproliferative disorder (MPD). A 20-year-old patient presented with fever, splenomegaly, marked leukocytosis (603×103/µl), and blasts in the peripheral blood. Since Ph chromosome and bcr-abl gene rearrangement were absent, the diagnosis of an unclassified MPD in the blast crisis phase was established. Immunophenotyping confirmed a biphenotypic crisis of myeloid and T-lymphoid antigens. The patient went into a complete remission after chemotherapy, but marked granulocytic hyperplasia (M:E ratio of 5.7) and 90% cellularity remained. Blast crisis recurred during subsequent intensification chemotherapy and the patient did not go into a complete remission regardless of the intense chemotherapy. The blast crisis transformed from unclassified MPD had a grave prognosis as it responded poorly to chemotherapy. This unique blast crisis is distinguishable from the blast crisis of chronic myelogenous leukemia.
引用
收藏
页码:603 / 604
页数:1
相关论文
共 50 条
  • [31] PLATELET PEROXIDASE-POSITIVE BLAST CELLS IN TRANSIENT MYELOPROLIFERATIVE DISORDER WITH DOWNS-SYNDROME
    SUDA, J
    EGUCHI, M
    OZAWA, T
    FURUKAWA, T
    HAYASHI, Y
    KOJIMA, S
    MAEDA, H
    TADOKORO, K
    SATO, Y
    MIURA, Y
    OHARA, A
    SUDA, T
    BRITISH JOURNAL OF HAEMATOLOGY, 1988, 68 (02) : 181 - 187
  • [32] The Wagner case: unclassified case
    Derny, Nicolas
    AVANT SCENE OPERA, 2020, (315): : 38 - 41
  • [33] PROLIFERATION AND DIFFERENTIATION OF UNCLASSIFIED LEUKEMIC BLAST CELLS IN CULTURE
    GANSER, A
    HOELZER, D
    EXPERIMENTAL HEMATOLOGY, 1985, 13 (05) : 417 - 417
  • [34] Biphenotypic leukaemia - a case report
    Walsh, S.
    Classen, C. F.
    KLINISCHE PADIATRIE, 2008, 220 (03): : 211 - 211
  • [35] Blast crisis
    Prasad, Aakanksha
    Asija, Amit
    BLOOD, 2009, 114 (24) : 4917 - 4917
  • [36] Accelerated and blast phase myeloproliferative neoplasms
    Saliba, Antoine N.
    Gangat, Naseema
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022, 35 (02)
  • [37] A case of V617F(+) myelodysplastic/myeloproliferative disorder
    Ozer, Ozden
    Eskazan, Emre
    Bekoz, Huseyin
    Peker, Kamil
    Yuksel, Sirin
    Altiok, Ender
    Ferhanoglu, Burhan
    VIRCHOWS ARCHIV, 2007, 451 (02) : 434 - 434
  • [38] Accelerated and Blast Phase Myeloproliferative Neoplasms
    Jain, Tania
    Rampal, Raajit K.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (02) : 325 - 335
  • [40] Gemcitabine and Gemcitabine plus Ara-C have significant activity on blast cells from patients with blast crisis chronic myeloproliferative disorders
    Santini, V
    Bernabei, PA
    Ippolito, GD
    Figuccia, M
    Zoccolante, A
    Ferrini, PR
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA II, 1997, 3 : 223 - 228